headache relief extra strength
Generic: acetaminophen, aspirin, caffeine
Labeler: p & l development, llcDrug Facts
Product Profile
Brand Name
headache relief extra strength
Generic Name
acetaminophen, aspirin, caffeine
Labeler
p & l development, llc
Dosage Form
TABLET
Routes
Active Ingredients
acetaminophen 250 mg/1, aspirin 250 mg/1, caffeine 65 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
59726-011
Product ID
59726-011_2b34081b-c474-44b7-a339-b31a666e5ade
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M013
Marketing Start
2021-06-25
Marketing End
2026-12-31
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
59726011
Hyphenated Format
59726-011
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
headache relief extra strength (source: ndc)
Generic Name
acetaminophen, aspirin, caffeine (source: ndc)
Application Number
M013 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/1
- 65 mg/1
Packaging
- 1 BOTTLE, PLASTIC in 1 BOX (59726-011-50) / 50 TABLET in 1 BOTTLE, PLASTIC
Packages (1)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2b34081b-c474-44b7-a339-b31a666e5ade", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0359726247504"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["c54ad829-f2e8-4367-b439-af20b0ef8ad2"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["P & L Development, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 BOX (59726-011-50) / 50 TABLET in 1 BOTTLE, PLASTIC", "package_ndc": "59726-011-50", "marketing_end_date": "20261231", "marketing_start_date": "20210625"}], "brand_name": "Headache Relief Extra Strength", "product_id": "59726-011_2b34081b-c474-44b7-a339-b31a666e5ade", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "59726-011", "generic_name": "Acetaminophen, Aspirin, Caffeine", "labeler_name": "P & L Development, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Headache Relief", "brand_name_suffix": "Extra Strength", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20261231", "marketing_start_date": "20210625"}